- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Human leukocyte antigen DR alpha (HLA-DRA) is a major histocompatibility complex class II protein encoded by the HLA-DRA gene and forms the alpha chain of the HLA-DR antigen receptor involved in peptide antigen presentation to CD4-positive T lymphocytes. HLA-DR Antibody Recombinant Rabbit MAb HLA-DRA/6839R recognizes the HLA-DR antigen complex, a widely used marker of major histocompatibility complex class II expression on antigen-presenting immune cells such as B lymphocytes, macrophages, and dendritic cells.
HLA-DR is a heterodimeric receptor composed of an alpha chain encoded by HLA-DRA and a beta chain encoded by HLA-DRB genes. Together these two chains form the HLA-DR antigen complex that binds peptides derived from extracellular proteins processed within endosomal compartments. The peptide-loaded HLA-DR complex is transported to the cell surface where it presents antigenic peptides to CD4-positive helper T lymphocytes. Through this antigen presentation pathway, the HLA-DR receptor plays a central role in adaptive immune activation and immune surveillance.
In immunology literature the HLA-DR receptor complex is often referred to simply as HLA-DR, and antibodies directed against this molecule are commonly described as HLA-DR antibodies, HLA-DR alpha antibodies, or MHC class II DR antibodies. HLA-DR antibody reagents therefore detect the HLA-DR antigen complex expressed on professional antigen-presenting cells and immune infiltrates present in tissues. Expression of HLA-DR alpha can be strongly induced by inflammatory cytokines such as interferon-gamma, resulting in increased MHC class II expression during immune activation, infection, autoimmune disease, and inflammatory responses.
Detection of HLA-DR expression using antibodies such as recombinant rabbit monoclonal clone HLA-DRA/6839R supports studies of immune activation, antigen presentation pathways, and immune cell characterization in both normal and disease contexts. Because HLA-DR expression reflects the presence and activation state of antigen-presenting immune cells, analysis of the HLA-DR alpha chain is widely used in immunology, pathology, and cancer research to evaluate immune infiltration and antigen presentation activity.
Optimal dilution of the HLA-DR antibody should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 1-200) from the human protein was used as the immunogen for the HLA-DR antibody.
Aliquot the HLA-DR antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
HLA-DR alpha antibody, HLA-DRA antibody, MHC class II DR antibody, HLA-DR antigen antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.